Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)

NCT: NCT07659743 · NOT_YET_RECRUITING

NCT IDNCT07659743
StatusNOT_YET_RECRUITING
Start Date2026-10-01
Completion2029-09-30
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and sham BreEStim and Transcutaneous Electrical Nerve Stimulation (TENS) in management of neuropathic pain in patients after spinal cord injury (SCI).

Frequently Asked Questions

What is BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)?

BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI) is a clinical trial registered under NCT07659743. Current status: NOT_YET_RECRUITING.

What is the status of NCT07659743?

The current status of NCT07659743 (BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)) is: NOT_YET_RECRUITING.

When did BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI) start?

BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI) started on 2026-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑